Combination HIV pill might be available in 2006

01/11/2006 | Los Angeles Times (tiered subscription model)

Gilead CEO John Martin says the triple combination HIV pill, to be sold with Bristol-Myers Squibb and Merck, may be on the market this year. Martin says his company will file with the FDA during the second quarter for approval of the drug, the first to combine three HIV medicines in a once-a-day pill.

View Full Article in:

Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ